Your browser doesn't support javascript.
loading
Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics.
Kim, Seok; Bang, Ji-In; Boo, Dachung; Kim, Borham; Choi, In Young; Ko, SooJeong; Yoo, Ie Ryung; Kim, Kwangsoo; Kim, Junmo; Joo, YoungHwan; Ryoo, Hyun Gee; Paeng, Jin Chul; Park, Jung Mi; Jang, Woncheol; Kim, Byungwon; Chung, Yangha; Yang, Dongyoon; Yoo, Sooyoung; Lee, Ho-Young.
Affiliation
  • Kim S; Office of eHealth Research and Business, Seoul National University Bundang Hospital, 173rd Street, Gumi-ro, Seongnam-si 436-707, Republic of Korea.
  • Bang JI; Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.
  • Boo D; Office of eHealth Research and Business, Seoul National University Bundang Hospital, 173rd Street, Gumi-ro, Seongnam-si 436-707, Republic of Korea.
  • Kim B; Office of eHealth Research and Business, Seoul National University Bundang Hospital, 173rd Street, Gumi-ro, Seongnam-si 436-707, Republic of Korea.
  • Choi IY; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Ko S; Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Yoo IR; Department of Biomedicine & Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim K; Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim J; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Joo Y; Medical Big Data Research Center, Seoul National University Medical Research Center, Seoul, Republic of Korea.
  • Ryoo HG; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.
  • Paeng JC; Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
  • Park JM; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jang W; Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim B; Department of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, Gyeonggido, Republic of Korea.
  • Chung Y; Department of Statistics, Seoul National University, Seoul, South Korea.
  • Yang D; Department of Statistics, Kyungpook National University, Daegu, South Korea.
  • Yoo S; Department of Statistics, Seoul National University, Seoul, South Korea.
  • Lee HY; Department of Statistics, Seoul National University, Seoul, South Korea.
Eur J Nucl Med Mol Imaging ; 49(10): 3547-3556, 2022 08.
Article in En | MEDLINE | ID: mdl-35362796
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Neoplasms, Second Primary Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Female / Humans / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Neoplasms, Second Primary Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Female / Humans / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article